Diabetes: Secondary Complications, Regulation and Innovation

-

Join your peers at the only conference dedicated to the leading causes of mortality and morbidity in diabetes, this autumn, in London. Our distinguished faculty unite the fields of pharmacology, nanotechnology and clinical medicine to target atherosclerosis, endothelial inflammation and end-stage renal disease.

SMi's unique program brings together the latest research from those at the forefront of attenuating the complications arising from hyperglycaemia, dyslipidaemia, and angiopathy.

“This conference is an excellent one stop shop to up-skill on current issues in diabetes therapy. I’m happy to chair what will no doubt be a very stimulating session.” – Phil Ambery, Medical Director, GlaxoSmithKline

Key Reasons to Attend:
• Receive clinical updates on novel GLP1 receptor agonists, and SLGT2 and DPP-4 inhibitors
• Utilise biomarkers and imaging for the development of novel therapies for diabetes
• Discuss new therapeutic targets to reduce hypertension, hyperkalaemia and endothelial inflammation in diabetes
• Remain abreast of new EU and FDA guidelines on clinical trials on risk-benefit assessment
• Capitalise on the effects of targeting RAAS, CCN2 and CCN3 inhibitors
• Review clinical results from the DEMAND study

Key Speakers Include:
• James F. List, Vice President and Full Development Lead, Dapagliflozin, Bristol-Myers Squibb
• John Wilding, Professor of Medicine & Honorary Consultant Physician, Head of Department of Obesity and Endocrinology, University of Liverpool Hospital
• Martin Siman, Director, Design and Interpretation Centre of Excellence, AstraZeneca
• Philip Ambery, Director, Clinical Development, GlaxoSmithKline
• Sandra Souza, Team Lead, Molecular Biomarkers, PPDM , Merck Sharp & Dohme

Diabetes: Secondary Complications, Regulation and Innovation, promises to be a unique platform for networking, problem solving and learning from timely case studies. This really is a unique event not to be missed.

Click here to find out more and/or book your place.


Location:
Marriott Hotel, Regents Park
UK
UK


Organizer: SMi Group Ltd

1 Oct 2013



All Upcoming Events
1 2 Next 
4th International Conference on Past and Present Research Systems of Green Chemistry16 Oct 2017
11th World Drug Delivery Summit16 Oct 2017
7th Annual Orphan Drugs and Rare Diseases UK18 Oct 2017
6th Global Congress on Mass Spectrometry (Mass Spectra 2017)18 Oct 2017
Pain Medicine 201719 Oct 2017
International Conference on Biotech Pharmaceuticals23 Oct 2017
Powering Precision Health Summit 201724 Oct 2017
CYTO ASIA 201725 Oct 2017
Macrophage Biology in the Single-Cell Era26 Oct 2017
Preclinical Development Operations Summit 201731 Oct 2017
Plant Genomics & Gene Editing Congress: USA2 Nov 2017
Partnerships in Biocontrol, Biostimulants & Microbiome Congress2 Nov 2017
BioData World Congress 20172 Nov 2017
4th Drug Discovery Innovation Programme2 Nov 2017
5th Microbiome R&D and Business Collaboration Forum: USA2 Nov 2017
The 2nd Probiotics Congress: USA2 Nov 2017
Recent Advances in Food Analysis (RAFA 2017)7 Nov 2017
Commercialization in China, Japan & Korea - Myths, Misconceptions & Possibilities9 Nov 2017
Commercialization in China, Japan & Korea - Myths, Misconceptions & Possibilities10 Nov 2017
Neuroscience 201711 Nov 2017
Superbugs & Superdrugs USA13 Nov 2017
Pharmaceutical Microbiology East Coast13 Nov 2017
4th Biosimilars North America15 Nov 2017
Lyophilization USA16 Nov 2017
2nd International Conference and Exhibition on Polymer Chemistry27 Nov 2017
Global Medicinal Chemistry & GPCR Leaders Summit27 Nov 2017
Ophthalmic Drugs Conference28 Nov 2017
Digital Pathology Congress30 Nov 2017
Microfluidics Congress: Europe4 Dec 2017
Synthetic Biology & Gene Editing Congress4 Dec 2017

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement